Literature DB >> 23396727

Epidemiology of hepatocellular carcinoma in sub-Saharan Africa.

Michael C Kew1.   

Abstract

Published incidences of hepatocellular carcinoma in the Black population of sub-Saharan Africa underestimate the true incidence of the tumor because of the many instances in which hepatocellular carcinoma is either not definitively diagnosed or is not recorded in a cancer registry. Despite this, it is manifestly evident that the tumor occurs commonly and is a major cause of cancer deaths in Black African peoples living in the sub-continent, particularly in those living in rural areas. 46,000 new cases of hepatocellular carcinoma have been recorded to be diagnosed in sub-Saharan Africa each year, and age-standardized incidences of the tumor as high as 41.2/100,000 persons/year have been documented. The highest incidence of hepatocellular carcinoma has been recorded in Mozambique. The tumor occurs at a young age in rural dwelling and, to a lesser extent, urban dwelling Black Africans. It is also more common in men than women, particularly in the younger patients. Cirrhosis co-exists with hepatocellular carcinoma in about 60% of patients and is equally common in the two sexes. The tumor is not only common in the Black African population, it also carries an especially grave prognosis, with about 93% of the patients dying within 12 months of the onset of symptoms. Caucasians living in the sub-continent have a low incidence of hepatocellular carcinoma and it occurs at an older age.

Entities:  

Mesh:

Year:  2013        PMID: 23396727

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  38 in total

Review 1.  Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Authors:  Mehmet Sayiner; Pegah Golabi; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

2.  Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer.

Authors:  Chao-Chi Yeh; Chih-Hung Hsu; Yu-Yun Shao; Wen-Ching Ho; Mong-Hsun Tsai; Wen-Chi Feng; Lu-Ping Chow
Journal:  Mol Cell Proteomics       Date:  2015-04-07       Impact factor: 5.911

3.  Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients<sup/>.

Authors:  Lina Cunha; Carla Carrilho; Nilesh Bhatt; Michella Loforte; Cremildo Maueia; Fabíola Fernandes; Assucena Guisseve; Francisco Mbofana; Fatima Maibaze; Liana Mondlane; Muhammad Ismail; Luzmira Dimande; Sheila Machatine; Nuno Lunet; Yu-Tsueng Liu; Eduardo Samo Gudo; Pascal Pineau
Journal:  Cancer Treat Res Commun       Date:  2019-03-16

4.  Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma.

Authors:  Manal M Hassan; Gehan Botrus; Reham Abdel-Wahab; Robert A Wolff; Donghui Li; David Tweardy; Alexandria T Phan; Ernest Hawk; Milind Javle; Ju-Seog Lee; Harrys A Torres; Asif Rashid; Renato Lenzi; Hesham M Hassabo; Yasmin Abaza; Ahmed S Shalaby; Sahin Lacin; Jeffrey Morris; Yehuda Z Patt; Christopher I Amos; Saira A Khaderi; John A Goss; Prasun K Jalal; Ahmed O Kaseb
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-01       Impact factor: 11.382

5.  Single center analysis of therapy and outcomes of hepatocellular carcinoma in Sub-Saharan Africa.

Authors:  Amir Sultan; Chimaobi M Anugwom; Zerihun Wondifraw; Grace A Braimoh; Abate Bane; Jose D Debes
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-08-09       Impact factor: 3.869

6.  Cost-effectiveness of Hepatitis B Virus Infection Screening and Treatment or Vaccination in 6 High-risk Populations in the United States.

Authors:  Harinder S Chahal; Marion G Peters; Aaron M Harris; Devon McCabe; Paul Volberding; James G Kahn
Journal:  Open Forum Infect Dis       Date:  2018-12-26       Impact factor: 3.835

Review 7.  Psychological Burden and Psycho-Oncological Interventions for Patients With Hepatobiliary Cancers-A Systematic Review.

Authors:  Johanna Graf; Andreas Stengel
Journal:  Front Psychol       Date:  2021-05-05

8.  Spinal cord compression: an unusual presentation of hepatocellular carcinoma.

Authors:  Hileni Taleni Nangolo; Larrea Roberto; Innocent Lule Segamwenge; Andreas Voigt; Fredrick Kidaaga
Journal:  Pan Afr Med J       Date:  2014-12-09

9.  Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.

Authors:  Ottovon Bismark Dakurah; Cynthia Raissa Tchuem Tamandjou; Moleen Zunza; Wolfgang Preiser; Tongai Gibson Maponga
Journal:  BMC Cancer       Date:  2021-06-19       Impact factor: 4.430

Review 10.  Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update.

Authors:  James Lok; Kosh Agarwal
Journal:  Viruses       Date:  2021-07-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.